Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences CellTech India 2015

Prithi Rajan's Biography

Prithi Rajan, Adjunct Faculty- Chemical Physiology, The Scripps Research Institute

Dr. Prithi Rajan’s expertise includes disease modeling and the identification and validation of novel cellular targets for human diseases using complex cell cultures as experimental platforms.One of her major interests is the innovative use of primary cultures and stem cells of mammalian origin to dissect mechanisms of cellular function. Her focus has largely spanned oncology and CNS.Dr. Rajan obtained her Ph.D. from Northwestern University, USA in Virology and postdoctoral training at Massachusetts General Hospital/Harvard Univ.,USA in neuronal regeneration. Dr. Rajan initiated her career in stem cell biology at the National Institutes of Health, USA in 1996, where she identified novel cellular mechanisms in glial biology. Since then she has held several leadership positions in academic and corporate R&D, including heading a program in Psychiatric Genomics, Inc, USA where her team pioneered the use of neural stem cells for screening drugs targeting psychiatric illnesses. In 2008, she was recruited to the Center for Stem Cell Research, Christian Medical College, Vellore, India. Dr. Rajan subsequently co-founded two companies Saarum Sciences and Sapien Biosciences in Hyderabad, India, with a focus on diagnostics, prognostics and drug discovery. She holds an Adjunct position in the Department of Chemical Physiology at The Scripps Research Institute, California, USA.

Prithi Rajan Image

Identifying and Validating Cellular Targets of Cancer using Somatic Stem Cells

Tuesday, 3 March 2015 at 12:40

Add to Calendar ▼2015-03-03 12:40:002015-03-03 13:40:00Europe/LondonIdentifying and Validating Cellular Targets of Cancer using Somatic Stem CellsCellTech India 2015 in Bangalore, IndiaBangalore,

This talk will discuss a couple of ideas where novel targets related to cancer, specifically gliomas, are studied using somatic stem cells along with other primary cultures.   Neural and mesenchymal stem cells are used as experimental paradigms to explore alternative activation of the Stat signalling pathway, and potential interactions between cells within the tumor vis-à-vis immune reactions.  The use of stem cell technology to study the cancer and stem cell states will also be discussed.  

Add to Calendar ▼2015-03-02 00:00:002015-03-03 00:00:00Europe/LondonCellTech India 2015CellTech India 2015 in Bangalore, IndiaBangalore,